Abstract:Early assessment of the efficacy of treatment is important in patients with breast cancer, whose routine adjuvant regimen frequently includes chemotherapy. Irrespective of the exact mechanisms involved in induction, the common early phenotypic marker of apoptosis is the expression on the outer cell membrane surface of phosphatidylserine, which avidly binds annexin V. (99m)Tc-labeled annexin V has been proposed for in vivo scintigraphic detection of apoptosis, albeit with contradicting results. This study was performed to define the time course of apoptosis induced by the chemotherapeutic agent paclitaxel in a model of virus-induced murine breast cancer.METHODS: The RIII virus induces an estrogen-dependent, slow-growing breast cancer; BALB-c/cRIII female mice with breast tumors averaging 10 mm were studied, both in baseline conditions and at various times after the intravenous administration of paclitaxel (equivalent to a human dose of 20 mg/70 kg of body weight). The biodistribution of (99m)Tc-annexin V was evaluated at baseline and then at 1, 3, 6, and 24 h after paclitaxel administration. Apoptotic and antiapoptotic markers were also evaluated in tumor samples obtained at the same time points: DNA breaks (terminal deoxynucleotidyl transferase biotin-dUTP nick-end labeling [TUNEL]), active caspase-3, apoptosis-inducing factor, and Bcl-2 protein.RESULTS: Baseline uptake of (99m)Tc-annexin V in breast tumors was about 2-fold higher than the uptake in normal breast tissue (demonstrating some ongoing apoptosis); tracer uptake increased at 1 and 3 h after paclitaxel administration (to almost double the baseline value) and then declined to levels even lower than baseline. Although no activation of the apoptosis-inducing factor mechanism was detected, a peak in TUNEL-positive tumor cells was reached 3 h after paclitaxel administration (to more than 6-fold the baseline level). The antiapoptotic marker Bcl-2 exhibited a biphasic pattern, with a maximum drop at 3 h, followed by return toward baseline levels at 6 h.CONCLUSION: These results define the time course of various biologic events taking place in this model of murine breast cancer after a proapoptotic insult (single-dose paclitaxel). Although confirming that in vivo uptake of (99m)Tc-annexin V reflects the degree of apoptosis, the study also suggests that the apoptotic response to antitumor therapy may differ from tumor type to tumor type. Therefore, contradicting results previously reported may depend on an inadequate time window chosen for imaging with (99m)Tc-annexin V.

Lipidomic Analysis of Apoptotic Hela Cells Induced by Paclitaxel.

New method for the analysis of cell cycle-specific apoptosis.

Comparative Lipidomics Analysis of Cellular Development and Apoptosis in Two Taxus Cell Lines

Molecular Pathways and Functional Analysis of Mirna Expression Associated with Paclitaxel-Induced Apoptosis in Hepatocellular Carcinoma Cells

Preparation of thermosensitive liposomes containing paclitaxel and their anticancer effect

Time Course of Paclitaxel-Induced Apoptosis in an Experimental Model of Virus-Induced Breast Cancer

Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensi-tive liposomes in rats

Differential Gene Expression Profiles in Paclitaxel-Induced Cell Cycle Arrest and Apoptosis in Human Breast Cancer MCF-7 Cells.

Effect of Themicrobial Lipopeptide on Tumor Cell Lines: Apoptosis Induced by Disturbing the Fatty Acid Composition of Cell Membrane

Activation of the Mitochondria-Driven Pathway of Apoptosis in Human PC-3 Prostate Cancer Cells by a Novel Hydrophilic Paclitaxel Derivative, 7-Xylosyl-10-deacetylpaclitaxel.

Effect of Liposome Encapsulated Paelitaxel on Cervical Carcinoma Cells in Vitro

Dna Microarray Reveals Different Pathways Responding To Paclitaxel And Docetaxel In Non-Small Cell Lung Cancer Cell Line

[Paclitaxel-Induced Apoptosis in ACC-2 Cells is Associated with the Arrest of G(2)/M].

Induction of apoptosis and role of paclitaxel-loaded hyaluronic acid-crosslinked nanoparticles in the regulation of AKT and RhoA

[Preparation of Cell Penetrating Peptide TAT and Cleavable PEGco-modified Liposomes Loaded with Paclitaxel and Its in Vitro Apoptosis Assay].

Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel.

Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells

Involvement of Mitochondrial Permeability Transition Pore Opening in 7-Xylosyl-10-deacetylpaclitaxel-induced Apoptosis.

The ClC-3 Chloride Channel Associated with Microtubules is a Target of Paclitaxel in Its Induced-Apoptosis

Potential Biomarkers for Paclitaxel Sensitivity in Hypopharynx Cancer Cell.

Effect of Paclitaxel-Induced Apoptosis on HL-60 Cells on Bcl-2 Gene Family